Product Information
BIKTARVY 50-200-25 MG TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $136.7401 per EA under NDC 61958250101. Its NADAC has been published 423 times since May 23, 2018.
BIKTARVY 50-200-25 MG TABLET
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarateStrength
50; 200; 25 mg/1; mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958250101
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA210251On Market Since
2/7/2018
Pharmacological Classes
Price Statistics
The NADAC for BIKTARVY 50-200-25 MG TABLET has been published 423 times since May 23, 2018, and over the history we have for it it has risen 44.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $136.7401 per EA |
|---|---|
| All-time high | $136.7403 (Apr 15, 2026) |
| All-time low | $94.7278 (May 23, 2018) |
| 52-week high | $136.7403 |
| 52-week low | $136.6967 |
| Median price | $115.6252 |
| Average price | $116.1296 |
| Largest weekly change | +5.9% (Jan 15, 2025) |
| Weeks tracked | 423 |
| Tracking since | May 23, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BIKTARVY 50-200-25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BIKTARVY 50-200-25 MG TABLET, manufactured by Gilead Sciences, Inc., is $136.7401 per EA (NDC 61958250101), effective Jun 24, 2026.
How has the price of BIKTARVY 50-200-25 MG TABLET changed over time?
Over the history we have for it, the NADAC for BIKTARVY 50-200-25 MG TABLET has risen 44.4%. It has been tracked across 423 weekly CMS publications since May 23, 2018.
What are the highest and lowest recorded NADAC prices for BIKTARVY 50-200-25 MG TABLET?
Since May 23, 2018, the NADAC for BIKTARVY 50-200-25 MG TABLET has ranged from a low of $94.7278 (May 23, 2018) to a high of $136.7403 (Apr 15, 2026), with a median of $115.6252 per EA.
Are there cheaper alternatives to BIKTARVY 50-200-25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BIKTARVY 50-200-25 MG TABLET, but none are currently priced below it.
Who manufactures BIKTARVY 50-200-25 MG TABLET?
BIKTARVY 50-200-25 MG TABLET (NDC 61958250101) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification